Assessing the Safety and Efficacy of Thoracoscopic Lung Biopsy in Patients with Interstitial Lung Disease
Background: Interstitial lung disease [ILD] is a difficult-to-treat disease. The patient continues treatment for his/her whole life. However, certain causes – when diagnosed - could change their treatment plan. Radiological investigations cannot elicit the underlying pathology 100%. Thus, transthora...
Guardado en:
Autores principales: | Mohamed Mustafa Elsheikh, Hussein Ahmad Abo-Elyazed, Kamel Abdelghaffar, Atef Alrifai, Salah Eldeen Semary |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Al-Azhar University, Faculty of Medicine (Damietta)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d538809c51946048ef5cb7c8fa06a3c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Biopsy of lung lesions under CT control
por: Miloslav Marel, et al.
Publicado: (2021) -
Clopidogrel-Induced Interstitial Lung Disease: A Case Report
por: An J, et al.
Publicado: (2021) -
The role of thoracoscopic lung biopsy in the management of children with solid organ malignancies and suspected lung metastases in a developing country
por: Mark Wagener, et al.
Publicado: (2021) -
Interstitial lung abnormalities – current knowledge and future directions
por: Gisli Thor Axelsson, et al.
Publicado: (2021) -
Interstitial Lung Disease in Connective Tissue Diseases: Survival Patterns in a Population-Based Cohort
por: Charlotte Hyldgaard, et al.
Publicado: (2021)